Microbix to Exhibit and Present at Prominent Conference
Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF), a Toronto-based innovator in life sciences, will be attending a significant conference that gathers leaders in diagnostic and laboratory medicine. The Association for Diagnostic & Laboratory Medicine (ADLM) event takes place in a vibrant city and runs from July 28 to 31. This gathering promises to bring together experts and businesses dedicated to advancing medical diagnostics.
Showcasing Quality Assessment Products
At the conference, Microbix will feature prominently among other leading companies. They will display their wide-ranging portfolio of Quality Assessment Products (QAPs™), designed to enhance the effectiveness of diagnostic tests, especially in the realms of infectious disease detection. These products play a vital role in ensuring the accuracy of both antigen and molecular tests, including PCR and NAAT technologies.
The Importance of Accurate Diagnostics
Diagnostics are critical in managing public health, particularly as the world faces emerging infectious diseases. Microbix is committed to ensuring that laboratories can rely on high-quality products to deliver accurate results. At the ADLM conference, the focus will be on their ongoing work which aids clinical laboratories in refining their quality management processes.
Presenting Groundbreaking Research
Also at ADLM, Microbix will share exciting findings from a pilot External Quality Assessment (EQA) program that utilizes their QAPs. Their presented work, intriguingly titled "Quality Control Rapid Response in Pre-Pandemic Preparedness Showcasing a Synthetic H5N1 Genetic Template," aims to address how current influenza A testing methods can accurately identify potential pandemic strains like H5N1. This research is crucial given the world’s ongoing concerns about emerging health threats.
Collaboration with Industry Partners
Microbix is not working in isolation; they have partnered with the American Proficiency Institute (API), which will present related findings. Their efforts exemplify the collaboration necessary in the medical field to fortify defenses against health crises. The convergence of these two organizations emphasizes their commitment to supporting health professionals in delivering precise diagnostic results.
Significance of H5N1 Testing
H5N1 is particularly concerning due to its potential to cause serious illness or death in a significant portion of those infected. By focusing on QA for these tests, Microbix ensures that laboratories are well-equipped to respond to public health emergencies efficiently. Amer Alagic, the Director of R&D at Microbix, has noted the importance of these products in safeguarding health and enhancing the accuracy of diagnostics.
Contact Information for Inquiries
For those interested in acquiring Quality Assessment Products or looking for more information about Microbix’s offerings, inquiries can be directed to their customer service through designated contact channels. They emphasize their readiness to support customers' varying needs within the diagnostics landscape.
About Microbix Biosystems Inc.
Microbix Biosystems Inc. stands as a key player in the global diagnostics arena. With a focus on creating proprietary biological products, they have established a robust infrastructure that supports the development of innovative solutions such as QAPs. Their commitment to quality and reliability has earned them global relevance, as evidenced by their international distribution networks.
The company is ISO 9001 & 13485 accredited and operates with various health and regulatory compliances overseeing their quality assurance processes.
Frequently Asked Questions
What is the main focus of Microbix at the ADLM conference?
Microbix will showcase its Quality Assessment Products (QAPs™) and present findings from a pilot EQA program concerning H5N1 testing.
Who is Microbix collaborating with for their presentations?
Microbix is collaborating with the American Proficiency Institute (API) for the research presentations at the conference.
What are QAPs™ and why are they important?
QAPs™ are Quality Assessment Products that help ensure accurate diagnostic testing, critical for managing infectious diseases.
How can interested parties purchase Microbix products?
Purchase inquiries can be directed to Microbix's customer service through their official contact details.
Where is Microbix Biosystems headquartered?
Microbix Biosystems is headquartered in Mississauga, Ontario, Canada, and operates on a global scale.
